inner-banner-bg

Journal of Future Medicine and Healthcare Innovation(JFMHI)

Breathing a Sigh of Relief: The Economic Cost of Alpha-1 Antitrypsin Deficiency

Abstract

Azhar ul Haque Sario

Imagine a thief silently slipping into your home, not stealing possessions, but something far more precious: your health and financial stability. This is the grim reality for those living with Alpha-1 Antitrypsin Deficiency (AATD). Miravitlles et al. (2022) shine a light on this silent thief, meticulously dissecting the direct medical costs associated with AATD. Their findings paint a stark picture.

PDF